Cigna management to meet with Piper Sandler » 09:2502/1902/19/20
Meeting to be held in Los…
Meeting to be held in Los Angeles, CA on February 21 hosted by Piper Sandler.
Amarin rises as Citi says Buy on selloff, accelerating Vascepa sales » 11:2002/1802/18/20
AMRN, RDY, HKMPF
Shares of Amarin (AMRN)…
Tesla target hikes headline today's top Wall Street calls » 10:3302/1802/18/20
TSLA, AAPL, AMRN, CTL, AEO, M
Check out today's top…
Fly Intel: Top five analyst upgrades » 10:1502/1802/18/20
AMRN, DUK, KN, BC, WWE
Catch up on today's…
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Amarin (AMRN) upgraded to Buy from Neutral at Citi with analyst Joel Beatty saying with the stock trading 27% lower since November, now is an attractive time to buy. 2. Duke Energy (DUK) upgraded to Outperform from Neutral at Credit Suisse with analyst Michael Weinstein sayin he sees last year's $2.5B equity forward that was issued to support any contingency associated with the Atlantic Coast Pipeline project as providing Duke Energy the flexibility to fund additional accretive organic growth in the meantime. 3. Knowles (KN) upgraded to Overweight from Neutral at Piper Sandler with analyst Harsh Kumar saying he expects the operational issues affecting March quarter gross margin and the demand concerns surrounding Chinese handsets to ease entering the June 2020 quarter. 4. Brunswick (BC) upgraded to Outperform from Market Perform at Raymond James with analyst Joseph Altobello saying Brunswick has emerged as the pure-play leader in the U.S. marine industry with a balanced portfolio across boats, engines and parts and accessories. 5. WWE (WWE) upgraded to Overweight from Equal Weight at Consumer Edge. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
Deutsche raises price targets in Managed Care on fading political risks » 08:3502/1802/18/20
ANTM, CI, CNC, CVS, HUM, MOH, UNH
The Democratic presidential candidates that represent the perceived risk to substantive healthcare reform are either fading quickly in the polls like Elizabeth Warren or appear unelectable like Bernie Sanders in the eyes of healthcare investors, Deutsche Bank analyst George Hill tells investors in a research note. Following the New Hampshire primary, the analyst sees fading political threats to healthcare reform. He suspects the multiple expansion rally for managed care organization stocks will continue. As such, Hill raised his price target for Buy-rated Anthem (ANTM) to $362 from $314, for Buy-rated Cigna (CI) to $288 from $258, for Buy-rated Centene (CNC) to $84 from $68, for Buy-rated CVS Health (CVS) to $109 from $97, for Hold-rated Humana (HUM) to $433 from $363, for Buy-rated Molina Healthcare (MOH) to $206 from $156 and for Hold-rated UnitedHealth (UNH) to $362 from $297.
Citi upgrades Amarin to Buy from Neutral after 27% selloff since November » 06:0502/1802/18/20
Citi analyst Joel Beatty…
Citi analyst Joel Beatty upgraded Amarin to Buy from Neutral with a price target of $24, down from $27. The shares closed Friday down 7c to $17.62. With the stock trading 27% lower since November, now is an attractive time to buy, Beatty tells investors in a research note. The analyst still believes Vascepa sales will "accelerate strongly" over the next couple years. Further, Amarin will likely emerge from the ongoing intellectual property litigation with Vascepa exclusivity largely intact, contends Beatty.
Amarin upgraded to Buy from Neutral at Citi » 06:0102/1802/18/20
Citi analyst Joel Beatty…
Citi analyst Joel Beatty upgraded Amarin to Buy from Neutral with a price target of $24, down from $27.
Omega Advisors takes new positions in Ferro, Workday, exits Marathon Petroleum » 11:0502/1402/14/20
FOE, WDAY, IQV, SSSS, SMTS, MPC, CTVA, TMO, MNI, NET, DD, FANG, ET, COOP, CCL, TRWH, CIM, ASPS, AMCX, ASPU, FISV, GOOGL, CI, UAL, WPX
Leon Cooperman's Omega Advisors disclosed in an SEC filing its holdings as of December 31, 2019. Omega's five new buys during the fourth quarter were, by size of position, Ferro (FOE), Workday (WDAY), Iqvia (IQV), Sutter Rock (SSSS), and Sierra Metals (SMTS). Omega exited six positions during the quarter, including by size of previous position, Marathon Petroleum (MPC), Corteva (CTVA), Thermo Fisher Scientific (TMO), McClatchy (MNI), and Cloudflare (NET). Omega increased its stake in 20 holdings, including by size of previous position, DuPont (DD), Diamondback Energy (FANG), Energy Transfer (ET), Mr. Cooper Group (COOP), and Carnival (CCL). Omega reduced its stake in nine holdings, including by size of previous position, Twin River (TRWH), Chimera (CIM), Altisource Portfolio Solutions (ASPS), AMC Networks (AMCX), and Aspen Group (ASPU). Omega's top holdings as of December 31, 2019, in order of size, were Fiserv (FISV), Alphabet Class A (GOOGL), Cigna (CI), United Airlines (UAL), and WPX Energy (WPX).
|Over a week ago|
Amarin story has 'too many unknowns,' InvestorPlace contributor says » 10:4002/1302/13/20
Dana Blankenhorn, an…
Dana Blankenhorn, an InvestorPlace contributor, wrote in an article published by the stock-idea sharing site: "Amarin stock is filled with known unknowns...The uncertainty is why I have recommended against buying Amarin shares. That and the fact I'm not about to get it. Not everyone will benefit from this drug. You need to see persistent high triglycerides, even with statin therapy, to be a real candidate for it." Reference Link
Cigna call volume above normal and directionally bullish » 11:0502/1202/12/20
Bullish option flow…
Bullish option flow detected in Cigna with 4,994 calls trading, 4x expected, and implied vol increasing over 3 points to 33.33%. Mar-20 210 calls and Feb-20 225 calls are the most active options, with total volume in those strikes near 1,400 contracts. The Put/Call Ratio is 0.47. Earnings are expected on April 30th.